| First Author | Read BJ | Year | 2022 |
| Journal | Cell Rep | Volume | 38 |
| Issue | 2 | Pages | 110217 |
| PubMed ID | 35021101 | Mgi Jnum | J:327096 |
| Mgi Id | MGI:6879560 | Doi | 10.1016/j.celrep.2021.110217 |
| Citation | Read BJ, et al. (2022) Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens. Cell Rep 38(2):110217 |
| abstractText | Nanoparticle (NP) vaccine formulations promote immune responses through multiple mechanisms. We recently reported that mannose-binding lectin (MBL) triggers trafficking of glycosylated HIV Env-immunogen NPs to lymph node follicles. Here, we investigate effects of MBL and complement on NP forms of HIV and other viral antigens. MBL recognition of oligomannose on gp120 nanoparticles significantly increases antigen accumulation in lymph nodes and antigen-specific germinal center (GC) responses. MBL and complement also mediate follicular trafficking and enhance GC responses to influenza, HBV, and HPV particulate antigens. Using model protein nanoparticles bearing titrated levels of glycosylation, we determine that mannose patches at a minimal density of 2.1 x 10(-3) mannose patches/nm(2) are required to trigger follicular targeting, which increases with increasing glycan density up to at least approximately 8.2 x 10(-3) patches/nm(2). Thus, innate immune recognition of glycans has a significant impact on humoral immunity, and these findings provide a framework for engineering glycan recognition to optimize vaccine efficacy. |
